Terminated PHASE4 INTERVENTIONAL NCT00152607

Orthotopic Liver Transplantation Using a Living Donor

Orthotopic Liver Transplantation Using a Living Donor Into An Adult Recipient

Sponsor: University of Chicago

Conditions Liver Disease Liver Neoplasms

Interventions donor right hepatic lobectomy

Updated 6 times since 2017 Last updated: Sep 26, 2013 Started: Apr 30, 2000 Primary completion: Sep 30, 2006 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Poor accrual

This PHASE4 trial investigates Liver Disease and Liver Neoplasms and is currently terminated or withdrawn. University of Chicago leads this study, which shows 6 recorded versions since 2000 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE4
Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Apr 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Chicago

Data source: University of Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States